Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature

Objectives. To review the available literature on medication-related osteonecrosis of the jaw (MRONJ) associated with antiangiogenics in antiresorptive-naïve individuals. Methods. A literature search was performed using MEDLINE via PubMed, EMBASE, and Web of Science in December 2017. Results. We ide...

Full description

Bibliographic Details
Main Authors:	Kununya Pimolbutr, Stephen Porter, Stefano Fedele
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/8071579

Similar Items

Serum biomarkers for antiresorptives-related osteonecrosis of the jaw: In vivo and clinical validation studies
by: Hye-Yeon Kim, et al.
Published: (2020-10-01)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
by: Akira Taguchi, et al.
Published: (2017-06-01)

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
by: Raquel D’Aquino Garcia Caminha, et al.

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019-11-01)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
by: Masaki Minabe, et al.
Published: (2020-12-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
by: Daniel Amaral Alves MARLIÉRE, et al.
Published: (2019-12-01)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
by: Roberto Sacco, et al.
Published: (2021-01-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
by: Julian Woolley, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.
by: Takuma Watanabe, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
by: Watanabe, Takuma
Published: (2021)

Osteonecrosis of jaw after antiangiogenic agent administration in a renal cell carcinoma patient
by: Tae-Young Jung, DDS, PhD
Published: (2017-06-01)

Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review
by: Mampei Kawahara, et al.
Published: (2021-05-01)

Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
by: Camilla Ottesen, et al.
Published: (2020-04-01)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
by: Giacomo Oteri, et al.
Published: (2018-01-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

Early Detection of Antiresorptive drug-Related Osteonecrosis of the Jaws (ARONJ) with Technetium-99m Methylene Diphosphonate-based Bone Scintigraphy
by: Anna Marie J. Miranda, et al.
Published: (2015)

Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy
by: Karsten Kern, et al.
Published: (2021-06-01)

Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
by: Eder Alberto Sigua-Rodriguez, et al.
Published: (2014-01-01)

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
by: Gianfranco Favia, et al.
Published: (2016-01-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012-01-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Osteonecrosis of the jaw in association to bisphosphonates
by: Mattos, Ana Carolina Lopes
Published: (2020)

Osteonecrosis of the jaw among patients receiving antiresorptive medication: A 4-year retrospective study at a tertiary cancer center, Kerala, India
by: Pramod S Sankar, et al.
Published: (2018-01-01)

ZOLEDRONATE-ASSOCIATED RECURRENCE OF OSTEONECROSIS OF JAWS
by: Rosen Tsolov, et al.
Published: (2020-10-01)

Osteonecrosis of jaw associated with bisphosphonate use
by: Ashu Rastogi, et al.
Published: (2012-01-01)

Imaging Findings of Bisphosphonates-Associated Osteonecrosis of Jaw: Literature Review and Report of 3 Cases
by: Lazar Adela Cristina, et al.
Published: (2016-03-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review
by: F. Capsoni
Published: (2011-09-01)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
by: Acquavella J, et al.
Published: (2016-07-01)

Nitrogen containing bisphosphonates associated osteonecrosis of the jaws: A review for past 10 year literature
by: Vijay Kumar, et al.
Published: (2014-01-01)

RANK-Ligand inhibitor associated osteonecrosis of the jaw
by: Rashad, Ashkan, et al.
Published: (2013-11-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

Osteonecrosis of the jaws: a review and update in etiology and treatment
by: Guilherme H. Ribeiro, et al.

Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review
by: Sakkas, Andreas, et al.
Published: (2021-04-01)

RISK FACTORS IN PATIENTS WITH BISPHOSPHONATE - ASSOCIATED OSTEONECROSIS OF THE JAWS
by: Meri Hristamyan, et al.
Published: (2021-01-01)

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
by: Britt-Isabelle Berg, et al.
Published: (2016-09-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Expert opinion about osteonecrosis of the jaw
by: Jeong Keun Lee, DDS, PhD
Published: (2017-06-01)

Cannot write session to /tmp/vufind_sessions/sess_67pcc00dbliv8f4o67ufa3oo52